The Bombay High Court has taken a stern stance against the Maharashtra government and the Food and Drug Administration (FDA) over their sluggish handling of business license suspensions. A bench comprising Acting Chief Justice Ravindra V. Ghuge and Justice Gautam A. Ankhad emphasized that administrative delays in reinstating licenses after compliance are extremely serious. The court remarked that such irresponsible inaction by officials not only subjects commercial establishments to heavy financial losses but also jeopardizes the livelihoods of employees and disrupts broader supply chains.
Background of the Dispute with Siddharth Agro
These observations came during the hearing of a petition filed by 'Siddharth Agro', a Pune-based firm engaged in the manufacturing of dairy products and animal feed. The conflict originated on July 15, when FDA officials conducted an unannounced inspection at the company's premises. Citing alleged violations under the Food Safety and Standards Act, the authority immediately suspended the enterprise's food license, prompting the company to challenge the action legally.
Following the suspension, the petitioner asserted that all identified deficiencies had been rectified and requested a fresh evaluation to verify regulatory compliance. However, FDA officials conducted a re-inspection on July 29 and claimed that multiple shortcomings persisted, refusing to revoke the suspension order. Faced with this administrative stalemate, the firm approached the High Court seeking intervention and a fair reassessment.
Court Orders Re-Inspection and Transparent Reporting
To resolve the impasse, the High Court directed the FDA to conduct a comprehensive fresh inspection on August 31. The bench mandated that the authorities formulate a complete compliance report detailing whether the business met the prescribed operational standards.
Furthermore, the court ordered officials to promptly supply the petitioner with a copy of the auto-generated report. This document is required to explicitly outline compliance scores and percentage breakdowns, ensuring total transparency regarding the regulatory findings and preventing arbitrary decision-making by inspectors.
Judicial Concerns Over Unnecessary Litigation
The bench expressed deep concern over instances where businesses remain burdened with license suspensions or cancellations even after resolving all highlighted issues. The court asserted that there is no justification for compelling a company to initiate litigation merely to set aside an administrative order that is no longer substantively valid.
The High Court pointed out that such legal disputes are entirely preventable and impose an unnecessary strain on both private enterprises and judicial resources. The bench added that a commercial entity that has taken corrective action to align with statutory norms cannot be subjected to further punitive consequences simply due to governmental inaction or delays.
Systemic Directives for Automatic Order Revocation
To ensure that the regulatory machinery operates in a fair, efficient, and equitable manner, the court issued overarching directions for future handling of similar cases. It mandated that once non-compliance issues are cleared, suspension orders should be promptly lifted across all regulatory matters.
Specific to Siddharth Agro, the bench ruled that upon the release of the auto-generated report confirming compliance, the initial suspension order issued in July will automatically be deemed revoked, provided the company adheres to all legal standards. The High Court further directed FDA officials to execute all necessary procedural formalities, including issuing formal administrative orders, without requiring the business to seek additional court orders.
